International Clinical Trial: Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07456930) titled 'Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment' on March 2.

Study Type: Observational

Primary Sponsor: Tools4Patient

Condition: Opioid Use Disorder

Recruitment Status: Not recruiting

Date of First Enrollment: June 1, 2026

Target Sample Size: 295

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07456930

Published by HT Digital Content Services with permission from Health Daily Digest....